Sullivan Christopher Ryan bought AVTX
May 7, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 18,606 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $183.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,606
Price
$9.88
Total value
$183.8K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 7, 2026
Filing dateMay 11, 2026
Shares owned after19,029
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.